ATRION CORPORATION (ATRI) Stock Fundamental Analysis
NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD
ATRI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. ATRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ATRI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ATRI was profitable.
In the past year ATRI had a positive cash flow from operations.
ATRI had positive earnings in each of the past 5 years.
In the past 5 years ATRI always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 4.82%, ATRI belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
ATRI has a better Return On Equity (5.26%) than 77.49% of its industry peers.
ATRI has a Return On Invested Capital of 5.13%. This is in the better half of the industry: ATRI outperforms 78.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ATRI is above the industry average of 7.92%.
The last Return On Invested Capital (5.13%) for ATRI is well below the 3 year average (11.35%), which needs to be investigated, but indicates that ATRI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROIC | 5.13% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
1.3 Margins
Looking at the Profit Margin, with a value of 6.92%, ATRI is in the better half of the industry, outperforming 78.53% of the companies in the same industry.
ATRI's Profit Margin has declined in the last couple of years.
The Operating Margin of ATRI (7.93%) is better than 75.39% of its industry peers.
ATRI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 32.08%, ATRI is doing worse than 72.25% of the companies in the same industry.
ATRI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% |
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
2. Health
2.1 Basic Checks
ATRI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ATRI has been reduced compared to 1 year ago.
Compared to 5 years ago, ATRI has less shares outstanding
There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ATRI has an Altman-Z score of 25.99. This indicates that ATRI is financially healthy and has little risk of bankruptcy at the moment.
ATRI has a better Altman-Z score (25.99) than 95.29% of its industry peers.
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 25.99 |
ROIC/WACC0.59
WACC8.7%
2.3 Liquidity
ATRI has a Current Ratio of 6.80. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
ATRI has a better Current ratio (6.80) than 81.68% of its industry peers.
ATRI has a Quick Ratio of 2.94. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ATRI (2.94) is better than 61.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 |
3. Growth
3.1 Past
ATRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.54%.
ATRI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.39% yearly.
ATRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.00%.
ATRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.13% yearly.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 64.50, ATRI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ATRI is valued a bit cheaper than 68.06% of the companies in the same industry.
ATRI is valuated expensively when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
ATRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ATRI is cheaper than 73.82% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ATRI indicates a rather cheap valuation: ATRI is cheaper than 84.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.25 | ||
| EV/EBITDA | 26.01 |
4.3 Compensation for Growth
The decent profitability rating of ATRI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.91%, ATRI has a reasonable but not impressive dividend return.
ATRI's Dividend Yield is rather good when compared to the industry average which is at 1.91. ATRI pays more dividend than 96.34% of the companies in the same industry.
ATRI's Dividend Yield is comparable with the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
5.2 History
The dividend of ATRI is nicely growing with an annual growth rate of 10.99%!
ATRI has been paying a dividend for at least 10 years, so it has a reliable track record.
ATRI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
5.3 Sustainability
ATRI pays out 123.31% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of ATRI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:ATRI (8/20/2024, 8:22:19 PM)
459.92
+0.26 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.01%
Inst Owner Change0%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A | ||
| P/S | 4.46 | ||
| P/FCF | 29.25 | ||
| P/OCF | 20.89 | ||
| P/B | 3.39 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 26.01 |
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROCE | 5.93% | ||
| ROIC | 5.13% | ||
| ROICexc | 5.53% | ||
| ROICexgc | 5.81% | ||
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% | ||
| FCFM | 15.24% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexcg growth 3Y-18.15%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 70.13% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 128.3% | ||
| Profit Quality | 220.39% | ||
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 | ||
| Altman-Z | 25.99 |
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%